This message contains images. If you don't see images, click here to view.
Advertise in this news brief.



  Mobile version   RSS   Subscribe   Unsubscribe   Archive   Media Kit |  Histology Marketplace:     

Home   History   Meeting Calendar   Career Center   Certification   Contact Us    



 




NSH NEWS

The NSH 2014 Laboratory Webinar Series now open for registration
NSH
Each year The National Society for Histotechnology offers a 12-month series of webinars for laboratories and their techs. This is a convenient and inexpensive way to earn 12 continuing education credits. The cost for each session is the same regardless of the number of attendees and all materials are good for two years to train new staff. View all webinar topics here. Get your registration in by Jan. 22, 2014 to receive the full 2014 series for only $1,350 or register online today!
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE  




TOP STORIES


Analyzing hundreds of cells in a few mouse clicks
Swiss Federal Institute of Technology in Lausanne via R&D Magazine
VideoBriefThe increasingly powerful microscopes used in biomedical imaging provide biologists with 3-D images of hundreds of cells, and cells in these images are often layered on each other. Under these conditions, it is impossible for traditional computational methods to determine the cells' properties (i.e., their size, shape and density) quickly. Ricard Delgado-Gonzalo's work at EPFL is about to change that. The EPFL Biomedical Imaging Group Ph.D. student has developed a virtual tool that can analyze dozens of images in just an hour — which works out to hundreds of cells. All it takes is a standard computer.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


SPONSORED CONTENT


HIV drugs may get new role in fighting cancer
Reuters
A type of HIV medicine that stops the AIDS virus from entering immune system cells could in future be put to work against cancer in new combination therapies being developed by drug companies. Interest in using so-called CCR5 inhibitors to fight tumors was fuelled last year when U.S. researchers, testing the drugs on mice, reported a marked reduction in aggressive breast cancer cells spreading to the animals' lungs.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Alzheimer's study reveals new genes implicated in disease
The Guardian
Researchers have taken a major step towards understanding the causes of Alzheimer's disease with the largest study yet into the genetics of the disorder. Findings from the international team suggest at least 20 genes play a role in the common late-onset form of Alzheimer's, more than double the number scientists had previously identified.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE




Recurrence of thyroid cancer 'could be predicted' with microRNAs
Medical News Today
New research has found that measuring sections of genetic material within papillary thyroid cancer tumors could predict the chance of recurrence following surgery, according to a study published in the journal Cancer. Researchers from Australia say they also discovered that elevated blood levels of this genetic material, known as microRNAs, could also indicate an increased chance of recurrence after thyroidectomy — the surgical removal of all or part of the thyroid gland.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE
Looking for similar articles? Search here, keyword microRNAs.


IN THE NEWS


Latest automation techniques in immunohematology testing
By Dr. Afsaneh Motamed-Khorasani
Automated analyzers have been used in many clinical laboratories since their discovery in mid-1950s. They have many advantages that include improved quality of preanalytical steps, reduced error rates and reduced individual exposure to biohazardous materials. Newer techniques such as column agglutination, solid-phase red cell adherence assay and erythrocyte-magnetized technology are being adapted in immunohematology.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


  PRODUCT SHOWCASES
Stellaris RNA FISH Probes


Stellaris RNA FISH is a new research technology that enables direct detection, localization and quantification of RNA. The low cost per assay, simple protocol, and the ability to localize mRNA and lncRNA to organelles and cellular structures provides obvious benefits for life science research. Custom and catalogued probes sets available. MORE
ergoCentric Laboratory Seating

Visit LabStorage System’s updated website to view details about this new laboratory seating with specially formulated Infection Control coating. Non-porous and easily disinfected, this moisture proof coating is anti-bacterial, anti-fungal and stain resistant. more
Spring Bioscience - BRAF V600E


Spring Bioscience is leading the research industry by pioneering novel, next generation antibodies that can differentiate mutant and normal protein, enabling pathologists to see relevant mutations within their cellular context. Having already released Exon19 and EGFR L858R for exclusive use by Ventana Medical Systems, Spring Bioscience has launched BRAF V600E.
Click here to find out more.


UB study to test possible drug target for myelin repair
University at Buffalo
In the quest to find a pharmaceutical target to repair myelin — the nerve sheath destroyed in multiple sclerosis — University at Buffalo researchers aim to test a drug that blocks the activity of the M3 receptor gene. Principal investigator Fraser J. Sim, Ph.D., assistant professor of pharmacology and toxicology, has received $555,000 for the project — one of three academic awards recently granted through the National Multiple Sclerosis Society's No Opportunity Wasted campaign.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Tricyclic antidepressants may be effective against an aggresive lung cancer
Oncology Nurse Advisor
A little-used class of antidepressants appears potentially effective in combating a particularly deadly form of lung cancer, according to a new study. Because the drugs are already FDA-approved for use in humans, the researchers were able to quickly launch a clinical trial to test their theory in patients. The phase II trial is now recruiting participants with small-cell lung cancer and other similar conditions such as aggressive gastrointestinal neuroendocrine cancers.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


  FEATURED COMPANIES
Sensitive and specific RNA-ISH Assay
QuantiGene® ViewRNA Assays enable single-molecule RNA detection in cells, CTCs, tissues, and TMAs. Assays for your genes of interest are developed in <1 week. Be amazed.
Produce the best IHC results

Download your IHC application guide and discover reagents to support every stage of your IHC workflow. Visit Abcam at Booth 3700,3701 at SFN 2013. DOWNLOAD NOW


HIV's battle scars tell of genome-to-genome conflict with human hosts
Genetic Engineering & Biotechnology News
The immune system's attacks on HIV leave their marks — genetic mutations that show how the virus responded. By studying these marks systematically, pairing genome-wide information from hosts and pathogens, researchers have created the first map of human HIV resistance. Ultimately, this information may point to new therapeutic targets and enable individualized treatment strategies.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


The use of biomarkers for renal carcinoma treatment
By Dr. Afsaneh Motamed-Khorasani
Renal cell carcinoma is the most common form of cancer, and it is responsible for more than 100,000 deaths per year all over the world. In recent years, significant advances have been achieved in understanding the renal carcinoma biology. This in-depth knowledge has led to the development of new therapeutic strategies. However, there has been no significant development in renal carcinoma detection tools in the past decade. Therefore, there is an urgent need for the use of biomarkers for the prognosis of RCC.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


TRENDING ARTICLES
Missed last week's issue? See which articles your colleagues read most.

    Suspicions about HPV vaccine explored in Preventive Medicine (Science Codex)
Nanotech system, cellular heating may improve treatment of ovarian cancer (R&D Magazine)
Hormones in BRCA gene carriers 'explain cancer risk' (Medical News Today)
FDA sets up rare disease research fund (PMLiVE)
Putting drug discovery back on target (Medical Xpress)

Don't be left behind. Click here to see what else you missed.


  PRODUCT SHOWCASES
RNAscope: Visualize Single-Copy RNA

RNAscope FFPE Assay Kits make detecting single-copy RNA easy. RNAscope works for virtually any gene in any tissue!

• Exquisite sensitivity & specificity
• Optimized for archival FFPE tissue
• Easy 7-hour IHC-like workflow
• Quantifiable and automatable
• New assays in < 3 weeks
• Guaranteed assay performance
Reduce Cost with Same Quality

GBI Labs produces the largest selection of secondary detection kits. We provide free samples to 1st time users. Staining with our kits results in similar or better sensitivity than other detection kits on the market. Some 110mL kits cost as little as $700.00 and 18 ml kit > $300.00.
To find out how to feature your company in Under the Microscope and other advertising opportunities, Contact James DeBois at 469-420-2618

More info
 

Under the Microscope
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Ashley Whipple, Senior Content Editor, 469.420.2642   
Contribute news

This edition of Under the Microscope was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here -- it's free!
Recent issues
Oct. 30, 2013
Oct. 23, 2013
Oct. 16, 2013
Oct 15, 2013 blast



7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063